About Theratechnologies (TSE:TH)
Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolTSE:TH
CUSIPN/A
Phone+1-514-3367800
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-33.47%
Return on Equity-38.09%
Return on Assets-22.70%
Miscellaneous
EmployeesN/A
Outstanding Shares74,962,000
Theratechnologies (TSE:TH) Frequently Asked Questions
What is Theratechnologies' stock symbol?
Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."
How were Theratechnologies' earnings last quarter?
Theratechnologies (TSE:TH) released its quarterly earnings data on Wednesday, February, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.02. The business earned $12.60 million during the quarter, compared to analyst estimates of $11.70 million. Theratechnologies had a negative net margin of 33.47% and a negative return on equity of 38.09%. View Theratechnologies' Earnings History.
When is Theratechnologies' next earnings date?
What price target have analysts set for TH?
3 Wall Street analysts have issued twelve-month price objectives for Theratechnologies' shares. Their forecasts range from C$9.25 to C$15.00. On average, they expect Theratechnologies' stock price to reach C$12.06 in the next year. View Analyst Ratings for Theratechnologies.
Who are some of Theratechnologies' key competitors?
Some companies that are related to Theratechnologies include Abcam (ABC), Sirtex Medical (SRX), Biotest (BIO), ProMetic Life Sciences (PLI), Genfit (GNFTF), Mesoblast (MSB), Oxford BioMedica (OXB), BioTime (BTX), Resverlogix (RVX), 22nd Century Group (XXII), Monash IVF Gr (MVF), Horizon Discovery (HZD), ImmunoVaccine (IMV), ImmunoVaccine (IMMVF) and Ampio Pharmaceuticals (AMPE).
Who are Theratechnologies' key executives?
Theratechnologies' management team includes the folowing people:
- Mr. Luc Tanguay, Chief Exec. Officer, Pres and Non-Independent Director (Age 60)
- Mr. Philippe Dubuc, Sr. VP & CFO (Age 51)
- Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 50)
- Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 55)
- Ms. Lyne Fortin, Sr. VP & Chief Commercial Officer (Age 58)
Has Theratechnologies been receiving favorable news coverage?
News coverage about TH stock has been trending somewhat positive on Monday, Accern reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Theratechnologies earned a media sentiment score of 0.22 on Accern's scale. They also assigned press coverage about the company an impact score of 45.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Theratechnologies?
Shares of TH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Theratechnologies' stock price today?
One share of TH stock can currently be purchased for approximately C$9.38.
How big of a company is Theratechnologies?
Theratechnologies has a market capitalization of C$737.77 million.
How can I contact Theratechnologies?
Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company can be reached via phone at +1-514-3367800.
MarketBeat Community Rating for Theratechnologies (TH)
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe TH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TH will underperform the S&P 500 over the long term. You may vote once every thirty days.
Theratechnologies (TSE:TH) Earnings History and Estimates Chart
Theratechnologies (TSE TH) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/11/2018 | | | | | | | | |
| 2/7/2018 | Q4 2017 | C($0.04) | C($0.06) | C$11.70 million | C$12.60 million | View | N/A |  |
| 10/5/2017 | Q3 2017 | C($0.03) | C($0.04) | C$11.00 million | C$11.22 million | View | N/A | |
| 7/12/2017 | Q2 2017 | C($0.03) | C($0.13) | C$11.20 million | C$10.02 million | View | N/A | |
| 4/6/2017 | Q1 2017 | C($0.01) | C($0.03) | C$10.60 million | C$9.04 million | View | N/A | |
| 10/4/2016 | Q3 2016 | C$0.01 | C$0.01 | C$9.45 million | C$8.93 million | View | N/A | |
| 7/5/2016 | Q2 2016 | C$0.02 | C($0.01) | C$11.75 million | C$9.03 million | View | N/A | |
| 2/24/2016 | Q4 2015 | C$0.03 | C$0.01 | C$10.50 million | C$9.01 million | View | N/A | |
| 10/1/2015 | Q3 2015 | | C$0.02 | | C$9.19 million | View | N/A | |
| 7/14/2015 | Q2 | C($0.02) | C$0.01 | C$6.45 million | C$7.08 million | View | Listen | |
| 4/14/2015 | Q1 2015 | C($0.03) | C($0.01) | C$4.02 million | C$4.57 million | View | N/A | |
| 2/26/2015 | Q4 2014 | C($0.09) | C($0.06) | C$2.33 million | C$2.66 million | View | N/A | |
| 10/8/2014 | Q3 2014 | | C($0.07) | | | View | N/A | |
| 7/9/2014 | Q2 2014 | | C$0.02 | | C$2.39 million | View | N/A | |
| 4/14/2014 | Q1 2014 | | C($0.06) | | C$1.67 million | View | N/A | |
| 2/27/2014 | Q4 2013 | | C($0.04) | | C$1.25 million | View | N/A | |
| 10/10/2013 | Q3 2013 | | C($0.03) | | C$2.18 million | View | N/A | |
| 7/10/2013 | Q2 2013 | | C($0.02) | | C$2.33 million | View | N/A | |
| 2/27/2013 | Q4 2012 | | C($0.02) | | | View | N/A | |
| 10/11/2012 | Q3 2012 | C($0.02) | C($0.01) | | | View | N/A | |
| 7/12/2012 | Q2 2012 | C($0.02) | C($0.02) | | | View | N/A | |
| 4/13/2012 | Q1 2012 | C($0.07) | C($0.06) | | | View | N/A | |
| 2/8/2012 | Q4 2011 | C($0.07) | C($0.03) | | | View | N/A | |
| 10/13/2011 | Q3 2011 | C($0.08) | C($0.06) | | | View | N/A | |
| 7/7/2011 | Q2 2011 | C($0.06) | C($0.10) | | | View | N/A | |
| 4/12/2011 | Q1 2011 | C($0.04) | C($0.10) | | | View | N/A | |
| 10/12/2010 | Q3 2010 | C($0.09) | C($0.08) | | | View | N/A | |
| 7/7/2010 | Q2 2010 | C($0.07) | C($0.11) | | | View | N/A | |
| 3/23/2010 | Q1 2010 | C($0.09) | C($0.07) | | | View | N/A | |
| 2/10/2010 | Q4 2009 | C($0.09) | C($0.11) | | | View | N/A | |
| 10/5/2009 | Q3 2009 | C($0.07) | C($0.11) | | | View | N/A | |
| 7/7/2009 | Q2 2009 | C($0.12) | C($0.09) | | | View | N/A | |
| 2/9/2009 | Q4 2008 | C$0.32 | C($0.17) | | | View | N/A | |
| 7/9/2008 | Q2 2008 | | C($0.20) | | | View | N/A | |
| 3/25/2008 | Q1 2008 | C($0.20) | C($0.20) | | | View | N/A | |
| 1/23/2008 | Q4 2007 | C($0.12) | C($0.19) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Theratechnologies (TSE:TH) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Theratechnologies (TSE TH) Insider Trading and Institutional Ownership History
Theratechnologies (TSE TH) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/10/2018 | Lyne Fortin | Insider | Sell | 1,000 | C$9.37 | C$9,370.00 | | |
| 4/9/2018 | Jean-Denis Talon | Director | Buy | 2,700 | C$9.44 | C$25,488.00 | | |
| 4/6/2018 | Denis Boucher | Insider | Buy | 400 | C$9.51 | C$3,804.00 | | |
| 11/15/2017 | Luc Tanguay | Director | Buy | 2,300 | C$6.64 | C$15,272.00 | | |
| 11/15/2017 | Philippe Dubuc | Insider | Buy | 1,000 | C$6.66 | C$6,660.00 | | |
| 7/18/2017 | Christian Marsolais | Insider | Buy | 3,000 | C$7.12 | C$21,360.00 | | |
| 7/17/2017 | Philippe Dubuc | Insider | Buy | 1,000 | C$8.00 | C$8,000.00 | | |
| 5/24/2017 | Philippe Dubuc | Insider | Buy | 600 | C$6.42 | C$3,852.00 | | |
| 4/7/2017 | Philippe Dubuc | Insider | Buy | 400 | C$5.89 | C$2,356.00 | | |
| 7/7/2016 | G�Rald A Lacoste | Director | Buy | 4,000 | C$2.36 | C$9,440.00 | | |
| 4/8/2016 | Philippe Dubuc | Insider | Buy | 3,300 | C$2.00 | C$6,600.00 | | |
| 4/7/2016 | Pierre Perazzelli | Director | Sell | 7,700 | C$1.95 | C$15,015.00 | | |
| 4/6/2016 | Pierre Perazzelli | Director | Sell | 6,500 | C$0.38 | C$2,470.00 | | |
| 4/5/2016 | Marie-No�L Colussi | Insider | Sell | 10,000 | C$2.04 | C$20,384.00 | | |
| 4/5/2016 | Pierre Perazzelli | Director | Sell | 6,500 | C$2.05 | C$13,325.00 | | |
| 6/26/2015 | G�Rald A Lacoste | Director | Buy | 10,000 | C$1.47 | C$14,700.00 | | |
| 5/22/2015 | Paul Pommier | Director | Buy | 20,300 | C$1.40 | C$28,420.00 | | |
| 5/21/2015 | Paul Pommier | Director | Buy | 25,000 | C$1.38 | C$34,500.00 | | |
| 5/5/2015 | Dawn Svoronos | Director | Buy | 5,000 | C$1.26 | C$6,300.00 | | |
| 5/1/2015 | Lyne Fortin | Insider | Buy | 9,900 | C$1.23 | C$12,177.00 | | |
| 4/30/2015 | Luc Tanguay | Director | Buy | 4,100 | C$1.19 | C$4,879.00 | | |
(Data available from 1/1/2013 forward)
Theratechnologies (TSE TH) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Theratechnologies Inc (TH) Director Jean-Denis Talon Acquires 2,700 Shares
www.americanbankingnews.com - April 9 at 4:12 PM |
| FY2018 EPS Estimates for Theratechnologies Inc (TH) Decreased by Analyst
www.americanbankingnews.com - April 9 at 1:54 AM |
 | BRIEF-Theratechnologies Reports Q1 Loss Per Share C$0.04
www.reuters.com - April 5 at 8:18 AM |
 | Theratechnologies Announces Financial Results for First Quarter of 2018
finance.yahoo.com - April 5 at 8:18 AM |
| Theratechnologies (TH) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 2 at 10:28 AM |
| Theratechnologies to Announce Financial Results for First Quarter 2018
finance.yahoo.com - March 29 at 3:57 PM |
 | New Positive Data on Trogarzo™ (ibalizumab-uiyk) Injection and EGRIFTA® (tesamorelin for injection) Presented at ... - GlobeNewswire (press release)
globenewswire.com - March 9 at 11:17 AM |
| National Bank Financial Analysts Lower Earnings Estimates for Theratechnologies Inc (TH)
www.americanbankingnews.com - March 9 at 10:17 AM |
 | Pollard, Theratechnologies at 52-Week Highs
www.baystreet.ca - March 8 at 4:36 PM |
 | Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the ... - PR Newswire (press release)
www.prnewswire.com - March 7 at 4:37 PM |
| Theratechnologies (TH) PT Raised to C$15.00
www.americanbankingnews.com - March 7 at 3:08 PM |
| Canaccord Genuity Boosts Theratechnologies (TH) Price Target to C$13.00
www.americanbankingnews.com - March 7 at 2:49 PM |
| Theratechnologies (TH) Price Target Raised to C$11.00
www.americanbankingnews.com - March 7 at 2:49 PM |
 | IIROC Trading Halt - TH
www.bizjournals.com - March 6 at 4:20 PM |
| Theratechnologies Inc (TH) Forecasted to Post FY2019 Earnings of $0.43 Per Share
www.americanbankingnews.com - February 12 at 8:28 AM |
| Theratechnologies Inc (TH) to Post FY2018 Earnings of $0.13 Per Share, National Bank Financial Forecasts
www.americanbankingnews.com - February 9 at 12:28 PM |
| Theratechnologies to Announce Financial Results for Fiscal Year 2017
finance.yahoo.com - February 7 at 8:46 AM |
| Theratechnologies Announces Financial Results for Fiscal Year 2017
finance.yahoo.com - February 7 at 8:46 AM |
| Theratechnologies, Inc. breached its 50 day moving average in a Bullish Manner : TH-CA : December 29, 2017
finance.yahoo.com - December 29 at 7:40 AM |
| Brokers Set Expectations for Theratechnologies Inc.'s FY2018 Earnings (TH)
www.americanbankingnews.com - November 18 at 8:52 AM |
| Theratechnologies Inc. (TH) Director Luc Tanguay Purchases 2,300 Shares
www.americanbankingnews.com - November 15 at 9:59 PM |
| Theratechnologies, Inc. – Value Analysis (TORONTO:TH) : November 14, 2017
finance.yahoo.com - November 15 at 2:43 PM |
| Theratechnologies Inc. (TH) Price Target Cut to C$8.75
www.americanbankingnews.com - November 14 at 2:28 PM |
| Theratechnologies, Inc. breached its 50 day moving average in a Bearish Manner : TH-CA : November 13, 2017
finance.yahoo.com - November 14 at 9:36 AM |
| Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018
finance.yahoo.com - November 14 at 9:36 AM |
| Calculating The Fair Value Of Theratechnologies Inc (TSX:TH)
finance.yahoo.com - November 5 at 7:05 AM |
| Theratechnologies, Inc. breached its 50 day moving average in a Bearish Manner : TH-CA : October 27, 2017
finance.yahoo.com - October 27 at 4:21 PM |
| Daily Coverage on Healthcare Stocks, Concordia International, ProMetic Life Sciences, Theratechnologies and Cardiome Pharma
finance.yahoo.com - October 23 at 8:15 AM |
| Theratechnologies, Inc. :TH-CA: Earnings Analysis: Q3, 2017 By the Numbers : October 9, 2017
finance.yahoo.com - October 10 at 7:26 AM |
| Research Analysts Set Expectations for Theratechnologies Inc's FY2018 Earnings (TH)
www.americanbankingnews.com - October 9 at 6:22 AM |
| Theratechnologies Inc (TH) Rating Increased to Outperform Market Weight at National Bank Financial
www.americanbankingnews.com - October 7 at 6:36 AM |
| Scotiabank Lowers Theratechnologies Inc (TH) Price Target to C$9.25
www.americanbankingnews.com - October 6 at 1:46 PM |
| Theratechnologies Inc (TH) Given New C$9.75 Price Target at National Bank Financial
www.americanbankingnews.com - October 6 at 1:44 PM |
| Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ - PR Newswire (press release)
www.prnewswire.com - October 6 at 11:17 AM |
| Theratechnologies Announces Financial Results for Third Quarter of 2017
finance.yahoo.com - October 6 at 11:17 AM |
| Theratechnologies reports 3Q loss
finance.yahoo.com - October 6 at 11:17 AM |
| Edited Transcript of TH.TO earnings conference call or presentation 5-Oct-17 12:30pm GMT
finance.yahoo.com - October 6 at 11:17 AM |
| Equities Analysts Issue Forecasts for Theratechnologies Inc's Q3 2017 Earnings (TH)
www.americanbankingnews.com - October 6 at 7:14 AM |
| Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017(TM)
finance.yahoo.com - October 4 at 10:06 AM |
| Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™
finance.yahoo.com - October 4 at 10:06 AM |
| Theratechnologies to Announce Financial Results for the Third Quarter of 2017
finance.yahoo.com - October 3 at 1:30 PM |
| Today's Research Reports on Theratechnologies, Aphria, Aurinia Pharmaceuticals and Theralase Technologies
finance.yahoo.com - October 3 at 1:30 PM |
| Theratechnologies Inc (TH) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - September 28 at 1:04 AM |
| Ibalizumab Long-Term Safety and Efficacy Data to be Presented at IDWeek 2017 in San Diego
finance.yahoo.com - September 19 at 8:25 AM |
| 5 Biotech Innovators Set To Excel In 2017
www.baystreet.ca - September 14 at 11:16 AM |
| Biotech Breakthroughs: 5 Stocks To Watch In 2017
www.baystreet.ca - September 12 at 10:57 AM |
| Canadian Healthcare Stocks Under Review, Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome Pharma
finance.yahoo.com - August 17 at 8:17 AM |
| Edited Transcript of TH.TO earnings conference call or presentation 12-Jul-17 12:30pm GMT
finance.yahoo.com - August 14 at 6:16 AM |
| Theratechnologies Issues Reminder Regarding Warrant Expiry
finance.yahoo.com - August 4 at 9:02 AM |
 | Theratechnologies’ shares on upward trajectory as new drugs move closer to market
www.theglobeandmail.com - August 3 at 7:54 AM |
Theratechnologies (TSE:TH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Theratechnologies (TSE TH) Stock Chart for Monday, April, 23, 2018
Loading chart…
